University Of Cambridge
Clinical trials sponsored by University Of Cambridge, explained in plain language.
-
Could Immune-Boosting drugs treat certain psychosis?
Disease control OngoingThis phase 2 trial tests whether a combination of intravenous immunoglobulin (IVIG) and rituximab can help people with psychosis caused by antibodies attacking the brain. 70 participants with acute psychosis and specific antibodies receive either the immunotherapy or a placebo. T…
Phase: PHASE2 • Sponsor: University of Cambridge • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Smart insulin pump could ease diabetes in cystic fibrosis patients
Disease control OngoingThis study tests whether a hybrid closed-loop system (CamAPS FX) can improve blood sugar control in people aged 16 and older with cystic fibrosis-related diabetes. The system combines an insulin pump, continuous glucose monitor, and smartphone app to automatically adjust insulin.…
Phase: NA • Sponsor: University of Cambridge • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Phone calls could save lives: new study tests vaccine reminders for displaced kids
Prevention ENROLLING_BY_INVITATIONThis study tests whether automated phone call reminders can help increase childhood vaccination rates among internally displaced families in Borno State, Nigeria. About 366 caregivers of young children will receive regular calls with reminders and health info in local languages. …
Phase: NA • Sponsor: University of Cambridge • Aim: Prevention
Last updated Jun 26, 2026 14:06 UTC